But the language of the internal self-assessment appears to confirm what both supporters and critics of the global body have ...

The company reaffirmed its 2025 earnings guidance of $4.67 to $4.82 per share, in line with analyst expectations of $4.75 per share. Eversource also maintained its long-term earnings per share growth ...

The global life and health reinsurer posted adjusted operating income of $5.66 per diluted share for Q1, beating analyst estimates of $5.44 per share. Net income available to RGA shareholders came in ...

However, Motorola Solutions provided weaker-than-anticipated guidance for the current quarter, projecting Q2 EPS of $3.32-$3.37, below the $3.48 consensus estimate. This outlook overshadowed the Q1 ...

Allison Transmission reaffirmed its full-year 2025 guidance, projecting net sales between $3.2 billion and $3.3 billion, below the analyst consensus of $3.37 billion. The company expects net income of ...

Investing.com -- Floor & Decor Holdings, Inc. (NYSE: FND) reported first quarter fiscal 2025 results that met analyst expectations, with shares rising 3.2% following the announcement.

Investing.com -- DexCom , Inc. (NASDAQ: DXCM) saw its shares jump 3.9% after the continuous glucose monitoring (CGM) device maker reported first-quarter revenue that surpassed analyst estimates, ...

Zeta Global posted a loss per share of -$0.10 for the first quarter, missing the analyst consensus of $0.12 earnings per share. However, the company’s revenue of $264 million exceeded the consensus ...

Despite the quarterly beat, Hologic reduced its fiscal 2025 earnings outlook. The company now expects full-year adjusted EPS of $4.15 to $4.25, down from its previous forecast of $4.25 to $4.35 and ...

However, Ryan Specialty reported a net loss of $4.4 million for the quarter, compared to net income of $40.7 million in the same period last year. The company attributed the loss primarily to higher ...

The Canadian gold miner posted adjusted earnings per share of $0.35, topping the consensus estimate of $0.32. Revenue rose 38% year-over-year to $355.2 million, exceeding expectations of $334.02 ...

The chemical manufacturer posted adjusted earnings per share of $0.01, beating the consensus estimate of -$0.08. Revenue came in at $1.64 billion, surpassing analyst projections of $1.58 billion and ...